See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!

Join us! · InformexUSA 2012 · New Orleans, Louisiana · February 14-17, 2012 · Booth 2514

Application · Receptor Biochemistry

· See all 100+ product categories

Item Number Product Sizes & Pricing CAS Purity Image Exclusive Introduction Date Mojo Plain Text Name Synonyms Keywords Interest
38612 13(S)-HODE-biotin - ≥98% (may contain trace amounts of free biotin) 21.322799263352 13-s-hode-biotin hydroxy fatty linoleic acids metabolites binding proteins receptors detection 13S-HODE-biotin 13(S)HODE-biotin 13S-HODES 13(S)-HODES 13-HODEs 13(S)HODEs 21.322799263352
10141 15-deoxy-Δ12,14-Prostaglandin J2-biotin - >98% 2005-10-11 34.721527229676 15-deoxy-12-14-prostaglandin-j2-biotin 15-deoxy-Δ12,14-PGJ2-biotin affinity probes binding proteins cyclopentenones PGs prostaglandins peroxisomes proliferator-activated receptors PPARs anitmitotic antiproliferative genes expressions non-classical non-GPCR gene protein-coupled detected detection interactions biotins ligands complexes nuclear nucleic acids elucidations mechanisms biotinylated PGJ2 biotinamides 34.721527229676
10008510 15(R)-Pinane Thromboxane A2 - >98% 2006-06-14 3.591104972376 15-r-pinane-thromboxane-a2 15(R)-PTA2 TXA2 anatagonists TP receptors synthases platelets aggregation analogs inhibits inhibitors inhibition U-46619 cat coronary artery constriction 15-epimer 3.591104972376
10118 15(R)-Prostaglandin D2 - >98% 59.398416206261 15-r-prostaglandin-d2 15(R)-PGD2 PGD2 vasodilation prostaglandins 15(R)-PGD2 15-epi-PGD2 15R-PGD2 DP2 receptors agonists CRTH2 endogenous 15d-pgj2 59.398416206261
34722 15(S)-HETE-biotin - ≥98% (may contain trace amounts of free biotin) 11.570690607734 15-s-hete-biotin hydroxy fatty acids binding proteins receptors detection 15S-HETE-biotin 15(S)HETE-biotin 15S-HETES 15(S)-HETES 15(S)HETEs 15-HETEs 15HETEs 11.570690607734
10005707 (2S)-OMPT - >98% 2005-10-19 32.475709023940 -2s-ompt GPR lysophosphatidic acids lipids mediators receptors LPA1/Edg-2 LPA2/Edg-4 LPA3/Edg-7 LPA4/GPR23 agonists calcium mobilization Sf9 cells (2R)-OMPT release assays LPA3-transfected rat hepatoma Rh7777 32.475709023940
10008436 8-iso-17-phenyl trinor Prostaglandin F2β - >98% 2006-06-14 10.634940805051 8-iso-17-phenyl-trinor-prostaglandin-f2 Bimatoprost analogs prostaglandins PGF2alpha PGF2.alpha. PGF2beta PGF2.beta. agonists 17-phenyl-trinor FP receptors inhibits inibitors inhibition isomers ophthalmology glaucoma IOP intraocular pressure ophthalmology 10.634940805051
10008370 AL 8810 methyl ester - >98% 2006-10-05 7.332928176795 al-8810-methyl-ester FP antagonists prostaglandins PGFs receptors AL8810 AL-8810 PGF2alpha PGF2.alpha. analogs esters intraocular 7.332928176795
10008640 Asthma Treatment Standard Set - 2006-07-13 5.285580110497 asthma-treatment-standard-set CysLT1 receptors cysteinyl leukotrienes asthma allergy antagonists LTC4 LTD4 hypersensitivity oral peptidyl LTRA bronchoconstriction montelukast pranlukast zafirlukast zileuton 10006967 packs 5.285580110497
10008612 azido-FTY720 - ≥98% 2006-09-13 51.265985267035 azido-fty720 sphingosine 1 phosphate S1P1 S1P3 S1P4 S1P5 immunosuppressant kinases photoreactive agonists analogs allograft transplants inhibits inhibitors inhibition lymphocytes emigration lymphoid organs in vivo Azido FTY720 FTY 720 51.265985267035
120112 BLT1 Receptor Blocking Peptide - ~30% 2.786961325966 blt1-receptor-blocking-peptide Leukotriene B4 Receptor 1; LTB4 Receptor 1; BLTR1 BLT-1 receptors leukotrienes controls peptides flow cytometry FACS ICC immunocytochemistry antibodies 2.786961325966
120111 BLT1 Receptor Monoclonal Antibody (Clone 7B1) - 29.184159431728 blt1-receptor-monoclonal-antibody-clone-7b1 Leukotriene B4 Receptor 1; LTB4 Receptor 1; BLTR1 LTB4R1 receptors antiserum antibodies leukotrienes neutrophils inflammation antisera flow cytometry immunocytochemistry icc immunohistochemistry ihc atherosclerosis FC 29.184159431728
120114 BLT1 Receptor Polyclonal Antibody - 6.257085635358 blt1-receptor-polyclonal-antibody Leukotriene B4 Receptor 1; LTB4 Receptor 1; BLTR1 LTB4R1 receptors antiserum antibodies leukotrienes neutrophils inflammation antisera flow cytometry immunocytochemistry icc WB western blots blotting immunohistochemistry ihc atherosclerosis immunoblotting FC 6.257085635358
100019 BLT1 Receptor Polyclonal Antiserum - 2.450441988950 blt1-receptor-polyclonal-antiserum Leukotriene B4 Receptor 1; LTB4 Receptor 1; BLTR1 C-terminus C-terminal intracellular plasma membranes whole cells LTB4R1 receptors antiserum antibodies leukotrienes neutrophils inflammation antisera flow cytometry immunocytochemistry icc WB western blots blotting immunohistochemistry ihc chronic pancreatitis pancreatic cancers pancreas atherosclerosis immunoblotting FC 2.450441988950
320124 BLT2 Receptor Blocking Peptide - 5.814994475138 blt2-receptor-blocking-peptide Leukotriene B4 Receptor 2; LTB4 Receptor 2; BLTR2 peptides controls receptors leukotrienes immunofluorescence flow cytometry FACs WB western blotting blots antibodies 5.814994475138
120124 BLT2 Receptor Polyclonal Antibody - 102.211368465787 blt2-receptor-polyclonal-antibody Leukotriene B4 Receptor 2; LTB4 Receptor 2; BLTR2 LTB4R2 LTB4-R2 receptors antiserum antibodies leukotrienes neutrophils inflammation antisera western blots blotting WB atherosclerosis immunoblotting 102.211368465787
13740 Butaprost Exclusive 69685-22-9 >98% ✓ 88.937265193369 butaprost TR 4979; 15-deoxy-16S-hydroxy-17-cyclobutyl PGE1 methyl ester PGE2 prostaglandins R-butaprost PGE1 methyl esters EP2 receptors (R)-butaprost (R)butaprost 88.937265193369
12050 BW 245C 72814-32-5 >98% 82.064516574585 bw-245c PGD2 hydantoins agonists BW245C prostaglandins BW-245C 82.064516574585
12060 BW A868C 118675-50-6 >98% 66.002306629834 bw-a868c hydantoin DP receptors antagonists BW245C adenylate cyclase antiaggregatory BWA868C BW-A868C BW-245C prostaglandins PGD2 DP1 66.002306629834
10007518 Capsazepine 138977-28-3 >98% 2006-03-29 10.181482504603 capsazepine vanilloid receptors 1 VR1 transient potential TRP endogenous stimuli tissues injury inflammation pain antagonists capsaicin Ca2+ neonatal rats dorsal root ganglias Chinese hamsters ovary ovaries cells 10.181482504603
10005186 CAY10441 Exclusive 221529-58-4 >98% ✓ 2004-09-16 119.233397790055 cay10441 RO1138452 receptors antagonists IPs prostaglandins carbaprostacyclins inhibits inhibitors inhibition analgesics high-affinity ligands neuroblastoma cyclic AMP cAMP adenylate cyclase 4,5-dihydro-1H-imidazol-2-yl-4-4-isopropoxy benzyl phenylamine atherosclerosis 119.233397790055
10005072 CAY10455 290374-09-3 >98% 2004-11-09 5.969205801104 cay10455 SKM 4-45-1 anandamides AEAs neurons fatty acid amide hydrolase FAAH analogs arachidonyl ethanolamides transporters acyl fluorescent fluorescence substrates cellular trafficking neurochemistry neuroscience 5.969205801104
10006735 CAY10471 627865-18-3 ≥98% 2005-06-22 16.284696132596 cay10471 ramatroban DP2 CRTH2 antagonists TP receptors prostaglandins PGD2 7-transmembranes GPCRs G protein-coupled BAY-u3405 human medications allergic rhinitis analogs 16.284696132596
10009524 ChREBP DBD (human recombinant) - >85% by SDS-PAGE 2007-04-12 2.659116022099 chrebp-dbd-human-recombinant GenBank Accession No. BC012925; Carbohydrate Response Element-binding Protein DNA Binding Domain EMSA electrophoretic mobility shift assays transcription factors proteins diabetes obesity insulin HLH MLXIPL MIO WBSCR14 endocrinology 2.659116022099
10006876 Diethylstilbestrol 56-53-1 ≥98% 2005-10-03 4.034618784530 diethylstilbestrol synthetics receptors agonists pregnant pregnancies linked breasts cancers congenital abnormalities abnormality offspring 3H-estradiols binding affinities affinity sexes hormones globulins SHBG estrogens 4.034618784530
13254 FTY720 phenoxy-biotin Exclusive - ≥95% ✓ 2009-10-28 67.725870165746 fty720-phenoxy-biotin sphingosine-1-phosphate S1P receptors S1P1 S1P3 S1P4 S1P5 immunosupression immune modulators transporters cPLA2 cytosolic phospholipase A2 biotins biotinylated biotinamide 67.725870165746
10008933 G-1 881639-98-1 ≥98% 2006-08-30 58.600331491712 g-1 GPR30 estrogen receptors ER ER.alpha. ER ER.beta. 17b-estradiol 17.beta.-estradiol 17beta-estradiol protein-coupled ERalpha ERbeta endoplasmic reticulum signaling agonists in vivo endocrinology 58.600331491712
10011038 Hemopressin - 2009-08-13 32.880710339384 hemopressin peptides antagonist inhibitors inhibits inhibition hypertension binding asoactive vasoactive cannabinoids cbs synthetic 32.880710339384
19600 I-BOP Exclusive 128719-90-4 ≥95% ✓ 66.318425414365 i-bop IBOP TXA2 analogs vasoconstriction agonists TP receptors 66.318425414365
19021 I-SAP 133538-58-6 ≥98% 5.328176795580 i-sap Iodophenyl sulfonyl amino pinane Thromboxane A2; Iodophenyl sulfonyl amino pinane TXA2 thromboxanes ISAP pinane analogs agtagonists TP receptors atherosclerosis 5.328176795580
10008131 JNJ-10198409 627512-69-0 ≥98% 2006-10-18 13.686453038674 jnj-10198409 PDGF-BB tyrosine kinases inhibits inhibition inhibitors growth factors receptors platelet-derived antiangiogenic antiproliferative coronary artery smooth muscle cells antagonists ATP binding hydrolysis tumors angiogenesis 13.686453038674
10009458 JTE-013 383150-41-2 ≥98% 2007-01-18 97.558465316145 jte-013 reverses inhibition inhibits coronary artery smooth muscles lipids cells proliferation cytoskeletal morphogenesis GPCRs protein-coupled receptors antagonists S1P2 humans rats EDG5 sphingosines sphingosine-1-phosphates sphingosine1 inhibitors JTE013 FDG-5 cancers 97.558465316145
10011565 L-161,982 147776-06-5 ≥98% 2009-02-26 59.377173112339 l-161-982 PGEs PGE2 EPs EP4 receptors antagonist bone formation inflammation cells proliferation colon cancers L161982 L-161982 59.377173112339
10008318 Montelukast (sodium salt) 151767-02-1 >98% 2006-04-20 16.462020520915 montelukast-sodium-salt Singulair® cysteinyl-leukotrienes cysLT1 receptors antagonists LTC4 LTD4 mediators asthma hypersensitivity bronchoconstriction microvascular permeability vasoconstrictors coronary arteries protein-coupled GPCRs selective potent 16.462020520915
10009818 NF-κB (p50) (human recombinant) - >75% 2007-06-20 45.398432320442 nf-b-p50-human-recombinant NF-κB1; Nuclear Factor-κB (p50) transcription factors proteins homodimers heterodimers p50/p105 p52/p100 RelA c-Rel genes cytokines chemokines immunoreceptors cell adhesion molecules DNA expression phosphorylation p ubiquitination subsequent degradation I.kappa.B.alpha. diseases therapeutics human nfkb nf-kb nf.-kappa.b nf.kappa.b 45.398432320442
10007697 N-Palmitoyl Dopamine 136181-87-8 >98% 2005-11-23 5.533591160221 n-palmitoyl-dopamine PALDA N-acyls fatty anologs N-araachidonoyl NADA N-oleoyl ODA bovine brains amides palmitic acids hybrids anandamides neurotransmitter pathways inactive vanilloid receptors 1 VR1 ligands hyperalgesics nocifensives responses in vivo entourage effects neurochemistry cannabinoids cbs synthetic 5.533591160221
10006803 O-1602 317321-41-8 >98% 2005-09-12 10.751519337016 o-1602 abnormal cannabidiols CB1 CB2 receptors vasorelaxation neurochemistry neuroscience central cannabinoids peripheral selective antagonists nonendothelium-dependant vasodilation nitric oxides NOs inhibits inhibitors inhibition vasorelaxant cannabinoids cbs synthetic 10.751519337016
10006804 O-1821 35482-50-9 >97% 2005-09-12 18.792081031307 o-1821 abnormal cannabidiol central cannabinoids peripheral CB1 CB2 receptors vasorelaxation neurochemistry neuroscience antagonists synthetic regioisomer endothelium dependent vasodilation cannabinoids cbs synthetic 18.792081031307
10004914 O-1918 536697-79-7 >98% 2005-09-09 9.388121546961 o-1918 antagonists abnormal cannabinoids cannabidiols cannabidiol-mediated synthetic regioisomers CB1 CB2 responsiveness psychotropics activity induces endothelium-dependent vasodilations NO-independent nitric oxides mechanisms analogs endothelial receptors inhibits inhibition inhibitors vasorelexants in vitro blocks induced activations PI3-kinases Akt pathway umbilical vein cells neuroscience neurochemistry O1918 0-1918 cannabinoids cbs synthetic 9.388121546961
10008642 oxy-Arachidonoyl Ethanolamide - >98% 2007-09-06 10.283609576427 oxy-arachidonoyl-ethanolamide oxy-Anandamide; oxy-AEA oxyanadamide arachidonylethanolamide AEA THC marijuana CB1 CB2 endocannabinoids receptors cannabinoids inhibitors 10.283609576427
360603 PAF Acetylhydrolase Blocking Peptide - 11.019060773481 paf-acetylhydrolase-blocking-peptide PAF-AH; Lp-PLA2; Platelet-activating Factor Acetylhydrolase western blots blotting controls peptides acetyl hydrolases IHC immunohistochemistry PAF-AH PAFs platlet-activating factors antibodies 11.019060773481
160604 PAF Receptor Blocking Peptide (Polyclonal) - ~30% 2.370718232044 paf-receptor-blocking-peptide-polyclonal Platelet-activating Factor Receptor platelet-activating factors Western blots controls peptides asthma inflammation receptors PAFs antibodies PAFR 2.370718232044
160600 PAF Receptor (human) Monoclonal Antibody (11A4, Clone 21) - 14.686232044199 paf-receptor-human-monoclonal-antibody-11a4-clone-21 Platelet-activating Factor Receptor platelet-activating factors antibodies PAFs ICC immunocytochemistry antisera antiserum flow cytometry FACS receptors atherosclerosis PAFR FC 14.686232044199
160602 PAF Receptor (human) Polyclonal Antibody - 14.014165745856 paf-receptor-human-polyclonal-antibody Platelet-activating Factor Receptor platelet-activating factors antisera PAFs antiserum antibodies flow cytometry facs immunocytochemistry icc western blots blotting wb atherosclerosis PAFR FC immunoblotting 14.014165745856
10009088 PPARα LBD (human recombinant) - ≥90% 2006-09-13 28.164267955801 ppar-lbd-human-recombinant Peroxisome Proliferator-activated Receptor α Ligand Binding Domain peroxisomes proliferator-activated receptors PPARs proliferator activated PPARalpha PPAR.alpha. PPARa PPARα PPAR-α PPAR-alpha alpha a α .alpha. PPAR-.alpha. PPAR-a recombinant proteins nuclear family families ligand activated trascription factors heterodimerize retinoic acids genes expression differentiation hNUC1 FAAR PPARβ PPARδ PPARγ liver skeletal muscles brown fats hearts kidneys livers fatty acids FAAH atherosclerotic lesions NSAIDs prostaglandins PGs leukotrienes B4 LTs LTB LTB4 WY 14643 WY-14643 WY14643 hypolipidemic CoA acyl-CoA oxidase enol-CoA hydratase dehydrogenase cytochromes P450 4A amino acids 170-430 E.coli gels electrophoresis coomassie statining western blots immunoblotting WB blotting 28.164267955801
61700 PPARγ FL (human recombinant from E. coli) - >90% by SDS-PAGE 2007-01-10 21.181080417433 ppar-fl-human-recombinant-from-e-coli Peroxisome Proliferator-activated Receptor γ Full Length (human recombinant) peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g human recombinant nuclear receptors ligands activated ligand-activated activates transcription factors heterodimerizes retinoic acids gene expression differentiation hormones subtypes PPARα PPARδ hNUC1 PPARβ pathology obese obesity diabetes atherosclerosis cancers adipose tissues expressed colon immune systems retina DNA binding domains binds DBD transcription factor assays 10006855 gel electrophoresis coomassie stains staining fluorescent displacement ANS rosiglitazone 21.181080417433
10009987 PPARγ FL (human recombinant from Sf21 cells) - ≥80% by SDS-PAGE 2007-06-15 61.004459352801 ppar-fl-human-recombinant-from-sf21-cells Peroxisome Proliferator-activated Receptor γ Full Length (human recombinant from Sf21 cells) proteins binding enzymes PPAR.gamma. PPARgamma diseases obesity diabetes atherosclerosis cancers endocrinology 61.004459352801
10007941 PPARγ LBD (human recombinant) - ≥90% 2006-03-16 19.116820135051 ppar-lbd-human-recombinant Peroxisome Proliferator-activated Receptor γ Ligand Binding Domain peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g recombinant proteins atherosclerosis diabetes endocrinology genes regulations metabolic syndrome nuclear receptors obese obesity PPAR proteins biochemistry hexahistidine-tagged tagged hexahistidine HIS-tag HIS-tagged HIS N-terminal PPARalpha PPAR.alpha. PPARα PPAR-alpha PPAR-.alpha. PPAR-α PPAR-delta PPAR-.delta. PPAR-δ PPARdelta PPAR.delta. PPARδ hNUC1 FAAR pathology diseases cancers domains LBD ligand binds binding DNA DBD RXR acid-like acid like heterodimerization thiazolidinedione rosiglitazone piolitazone insulin type II E. coli coomassie stains staining western blots blotting immunoblotting WB fluorescent 19.116820135051
10007451 PPARδ (human recombinant) - ≥95% 2005-07-29 11.494211172498 ppar-human-recombinant FAAR; PPARβ; Peroxisome Proliferative Activated Receptor δ; Nuclear Hormone Receptor 1; NUC1 peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d recombinant proteins human atherosclerosis cancers EMSA electrophoretic mobility shift assays endocrinology fluorescence metabolic syndrome nuclear obese obesity biochemistry transcription factors members retionic acids genes expression developments baculovirus Sf21 heterodimerize subtypes hNUC1 FAAR ubiquitously tissues mediator embryo implantation overexpression systems gels coomassie stains staining western blots WB immunoblotting 10006914 11.494211172498
10008593 PSN375963 388575-52-8 >98% 2006-08-01 17.340154696132 psn375963 GPR119 SNORF25 agonists oleoylethanolamide OEA obesity appetite food intake GPCR G protein-coupled receptors PSN632408 weight gain pancreas gastrointestinal tract brain endocrinology 17.340154696132
10008594 PSN632408 Exclusive 857652-30-3 >98% ✓ 2006-08-01 84.541160220994 psn632408 GPR119 SNORF25 agonists oleoylethanolamide OEA obesity appetite food intake GPCR G protein-coupled receptors PSN632408 weight gain pancreas gastrointestinal tract brain endocrinology neurochemistry 84.541160220994
10006045 (R)-Butaprost (free acid) - >98% 2004-11-09 20.071726519336 -r-butaprost-free-acid 15-deoxy-16R-hydroxy-17-cyclobutyl PGE1; (±)-15-deoxy-16R-hydroxy-17-cyclobutyl PGE1 PGE2 prostaglandins 5,6-dehydro-butaprost free acids EP2 receptors binding selectivity carboxylic acid selective analogs C-16 (R)-epimers 20.071726519336
19025 SQ 29,548 98672-91-4 ≥98% 87.390994475138 sq-29-548 thromboxanes TXA2 SQ-29548 SQ29548 analogs TP antagonists receptors atherosclerosis 87.390994475138
10005440 Tafluprost 209860-87-7 >98% 2004-10-05 236.322872928176 tafluprost AFP-168 eyes glaucoma prostaglandins agonists FP receptors ophthalmology ophthalmological intraocular acids 17-phenyl trinor-PGF2.alpha. 17-phenyl trinor-PGF2alpha 15-deoxy-15,15-difluoro PGF analogs 16-phenoxy hypotensive 236.322872928176
10005439 Tafluprost (free acid) 209860-88-8 >98% 2004-09-22 41.529889502762 tafluprost-free-acid AFP-172 eyes glaucoma prostaglandins agonists FP receptors ophthalmology ophthalmological intraocular AFP172 hypotensives pressure IOP 41.529889502762
13258 Tamoxifen 10540-29-1 ≥98% 2010-01-21 80.836114180478 tamoxifen nuclear receptors 17β-estradiol estrogen ERα ERβ modulators antagonists breast cancers tumors agonists bones osteoporosis cardiovascular disease menopause women uterus uterine endometrial carcinomas Nolvadex Istubal Valodex Savient brand of Tamoxifen Citrate Citrate Tamoxifen Tamoxifen Citrate Zitazonium Tomaxithen ICI-4 474 ICI 46 474Tamoxifen ICI-47699 ICI-46474 ICI46474ICI 47699 ICI 46474 Soltamox Novaldex Nolvadex ICI47699 ICI46474 80.836114180478
10007565 Tetradecyl Phosphonate 4671-75-4 >98% 2005-10-17 43.010149960536 tetradecyl-phosphonate pan-antagonists LPA receptors lysophosphatic acids lipids signalling molecules hydrolysis lysophospholipase D autotoxin signals GPCRs G-protein coupled LPA1/EDG-2 LPA2/EDG-4 LPA3/EDG-7 LPA4/GPR23 activates activation PPAR.gamma. peroxisomes proliferator-activated inhibits inhibition LPA-induced calcium mobilization activates reporter 43.010149960536
10007452 Vinclozolin M2 83792-61-4 >98% 2005-10-19 178.988549723756 vinclozolin-m2 M2 M1 antiandrogen androgens receptors fungicides antagonists rats dicarboximides controls diseases Botrytis cineera Sclerotinia sclerotiorum Monilinia grapes fruitss vegetables ornamentals plants turfgrass metabolites fathead minnows high-affinity low capacity testosterones binding sites brain ovary cytosolic functions endocrinology 178.988549723756
10010992 W123 Exclusive - ≥98% ✓ 2008-11-14 52.076132596685 w123 FTY720 sphingosines sphingosine-1-phosphate receptors S1P S1P1 EDG1 EDG-1 inhibitors inhibits inhibition SEW2871 FTY 720 antagonist 52.076132596685
Other Resources
Management Team Company Profile Company History ChemAssistant Tools FAQs Cayman Europe Cayman Pharma CaBRI Cayman Gear Press Releases Illustrations and Charts Key Research Area Posters Article Library Analysis Tools Conference Schedule Order Terms Browser Recommendation Privacy Statement Site Map

Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA

Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640

Copyright 2012 Cayman Chemical Company

Lost password?